Cargando…

Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis

INTRODUCTION: Global prevalence estimates for chronic kidney disease (CKD) in rheumatoid arthritis (RA) vary. This study assessed real-world prevalence estimates of renal impairment, based on estimated glomerular filtration rate (eGFR), among commercially insured patients with RA in the United State...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giles, Jon T., Simon, Lee S., Pope, Janet, Paik, Jim S., Grabner, Michael, Quebe, Amanda, Kannowski, Carol L., Salinas, Claudia A., Curtis, Jeffrey R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380618/ https://www.ncbi.nlm.nih.gov/pubmed/34319539 http://dx.doi.org/10.1007/s40744-021-00346-4

Ejemplares similares

Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US
por: Walton, Alison, et al.
Publicado: (2021)

Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis
por: Michaud, Kaleb, et al.
Publicado: (2021)

Comparing cardiovascular risk of patients with rheumatoid arthritis within the Social Security Disability Insurance with those commercially insured
por: Navarro-Millán, Iris, et al.
Publicado: (2022)

Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM
por: Fautrel, Bruno, et al.
Publicado: (2019)

Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population
por: Kern, David M., et al.
Publicado: (2018)

Estimation of Minimally Important Differences and Patient Acceptable Symptom State Scores for the Patient‐Reported Outcomes Measurement Information System Pain Interference Short Form in Rheumatoid Arthritis
por: Katz, Patricia, et al.
Publicado: (2020)

Management of Fatigue in Rheumatoid Arthritis
por: Pope, Janet E
Publicado: (2020)

No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients
por: Pyenson, Bruce S., et al.
Publicado: (2019)

Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study
por: Nowell, William Benjamin, et al.
Publicado: (2019)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Economic burden of acute steroid-refractory graft-versus-host disease in commercially insured pediatric patients
por: Grabner, Michael, et al.
Publicado: (2021)

Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn’s disease and ulcerative colitis in the United States
por: Gibble, Theresa Hunter, et al.
Publicado: (2023)

Validation of an Algorithm to Identify Venous Thromboembolism in Health Insurance Claims Data Among Patients with Rheumatoid Arthritis
por: Kim, Sangmi, et al.
Publicado: (2023)

Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis—going beyond treat to target
por: Taylor, Peter C., et al.
Publicado: (2021)

Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy
por: Taylor, Peter C., et al.
Publicado: (2022)

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population
por: Funch, Donnie, et al.
Publicado: (2019)

Consistency and Adequacy of Public and Commercial Health Insurance for US Children, 2016 to 2021
por: Daw, Jamie R., et al.
Publicado: (2023)

Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis
por: Giles, Jon T, et al.
Publicado: (2005)

Trends of lymphoma incidence in US veterans with rheumatoid arthritis, 2002–2017
por: Singh, Namrata, et al.
Publicado: (2020)

The impact of a regional patient-centered medical home initiative on cost of care among commercially insured population in the US
por: Maeng, Daniel Dukjae, et al.
Publicado: (2016)

Ambulatory Health Care Service Use and Costs Among Commercially Insured US Adults With Congenital Heart Disease
por: Agarwal, Anushree, et al.
Publicado: (2020)

Physician global assessments for disease activity in rheumatoid arthritis are all over the map!
por: Turk, Matthew, et al.
Publicado: (2018)

Characteristics and health care utilization of otherwise healthy commercially and Medicaid-insured preterm and full-term infants in the US
por: McLaurin, Kimmie K, et al.
Publicado: (2019)

Systemic overuse of health care in a commercially insured US population, 2010–2015
por: Oakes, Allison H., et al.
Publicado: (2019)

Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016
por: Pauly, Nathan J., et al.
Publicado: (2020)

Costs of Severe Maternal Morbidity in U.S. Commercially Insured and Medicaid Populations: An Updated Analysis
por: Black, Christopher M., et al.
Publicado: (2021)

Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018
por: Fang, Hanming, et al.
Publicado: (2022)

Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
por: Wallace, Beth I., et al.
Publicado: (2021)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial
por: Taylor, Peter C., et al.
Publicado: (2019)

Cervical spine involvement in rheumatoid arthritis over time: results from a meta-analysis
por: Zhang, Tony, et al.
Publicado: (2015)

Functional Impairment and Periodontitis in Rheumatoid Arthritis
por: Hashimoto, Hiroko, et al.
Publicado: (2022)

More surgery in December among US patients with commercial insurance is offset by unrelated but lesser surgery among patients with Medicare insurance
por: Dexter, Franklin, et al.
Publicado: (2022)

Dispositional Affect in Unique Subgroups of Patients with Rheumatoid Arthritis
por: Rice, Danielle B., et al.
Publicado: (2016)

Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis
por: Grabner, Michael, et al.
Publicado: (2017)

The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review
por: Taylor, Peter C., et al.
Publicado: (2021)

Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population
por: Kappelman, Michael D., et al.
Publicado: (2012)

Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
por: Broder, Michael S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3fn6rfdg3g876hftdfo8r9ktra